152 related articles for article (PubMed ID: 33475023)
1. Association between MeCP2 and Smad7 in the pathogenesis and development of pathological scars.
Li D; Yang E; Zhao J; Zhang H
J Plast Surg Hand Surg; 2021 Oct; 55(5):284-293. PubMed ID: 33475023
[TBL] [Abstract][Full Text] [Related]
2. TIEG1 Represses Smad7-Mediated Activation of TGF-β1/Smad Signaling in Keloid Pathogenesis.
Hu ZC; Shi F; Liu P; Zhang J; Guo D; Cao XL; Chen CF; Qu SQ; Zhu JY; Tang B
J Invest Dermatol; 2017 May; 137(5):1051-1059. PubMed ID: 28108300
[TBL] [Abstract][Full Text] [Related]
3. Decreased expression of inhibitory SMAD6 and SMAD7 in keloid scarring.
Yu H; Bock O; Bayat A; Ferguson MW; Mrowietz U
J Plast Reconstr Aesthet Surg; 2006; 59(3):221-9. PubMed ID: 16676428
[TBL] [Abstract][Full Text] [Related]
4. [Effects of silencing Smad ubiquitination regulatory factor 2 on the function of human hypertrophic scar-derived fibroblasts].
Zhang Z; Kuang F; Liu CL; Chen B; Tang WB; Li XJ
Zhonghua Shao Shang Za Zhi; 2017 Mar; 33(3):145-151. PubMed ID: 28316163
[No Abstract] [Full Text] [Related]
5. Smad7 down-regulation via ubiquitin degradation mediated by Smurf2 in fibroblasts of hypertrophic scars in burned patients.
Zhang Z; Liu C; Chen B; Tang W; Liu Z; Cao W; Li X
Burns; 2021 Sep; 47(6):1333-1341. PubMed ID: 33436154
[TBL] [Abstract][Full Text] [Related]
6. Hypertrophic and keloid scars fail to progress from the CD34
Limandjaja GC; Belien JM; Scheper RJ; Niessen FB; Gibbs S
Br J Dermatol; 2020 Apr; 182(4):974-986. PubMed ID: 31206605
[TBL] [Abstract][Full Text] [Related]
7. Asiaticoside suppresses collagen expression and TGF-β/Smad signaling through inducing Smad7 and inhibiting TGF-βRI and TGF-βRII in keloid fibroblasts.
Tang B; Zhu B; Liang Y; Bi L; Hu Z; Chen B; Zhang K; Zhu J
Arch Dermatol Res; 2011 Oct; 303(8):563-72. PubMed ID: 21240513
[TBL] [Abstract][Full Text] [Related]
8. MeCP2 epigenetically regulates alpha-smooth muscle actin in human lung fibroblasts.
Xiang Z; Zhou Q; Hu M; Sanders YY
J Cell Biochem; 2020 Jul; 121(7):3616-3625. PubMed ID: 32115750
[TBL] [Abstract][Full Text] [Related]
9. Studies of transforming growth factors beta 1-3 and their receptors I and II in fibroblast of keloids and hypertrophic scars.
Bock O; Yu H; Zitron S; Bayat A; Ferguson MW; Mrowietz U
Acta Derm Venereol; 2005; 85(3):216-20. PubMed ID: 16040405
[TBL] [Abstract][Full Text] [Related]
10. Expression of Smad protein by normal skin fibroblasts and hypertrophic scar fibroblasts in response to transforming growth factor beta1.
Xie JL; Qi SH; Pan S; Xu YB; Li TZ; Liu XS; Liu P
Dermatol Surg; 2008 Sep; 34(9):1216-24; discussion 1224-5. PubMed ID: 18616749
[TBL] [Abstract][Full Text] [Related]
11. [The expression of fibrillin 1 in pathologic scars and its significance].
Nie FF; Wang Q; Qin ZL
Zhonghua Zheng Xing Wai Ke Za Zhi; 2008 Sep; 24(5):339-42. PubMed ID: 19119630
[TBL] [Abstract][Full Text] [Related]
12. The role of altered fatty acid in pathological scars and their dermal fibroblasts.
Yang JX; Li SY; Chen ML; He LR
Chin J Traumatol; 2022 Jul; 25(4):218-223. PubMed ID: 35478090
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of USP4 attenuates pathological scarring by downregulation of the TGF‑β/Smad signaling pathway.
Zhang J; Na S; Pan S; Long S; Xin Y; Jiang Q; Lai Z; Yan J; Cao Z
Mol Med Rep; 2019 Aug; 20(2):1429-1435. PubMed ID: 31173246
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow derived mesenchymal stem cells inhibit the proliferative and profibrotic phenotype of hypertrophic scar fibroblasts and keloid fibroblasts through paracrine signaling.
Fang F; Huang RL; Zheng Y; Liu M; Huo R
J Dermatol Sci; 2016 Aug; 83(2):95-105. PubMed ID: 27211019
[TBL] [Abstract][Full Text] [Related]
15. [Expression of Smads in keloid scarring].
Tang B; Zhu B; Bi LK; Xue CL; Cai H; Zhu JY
Zhonghua Wai Ke Za Zhi; 2009 Jun; 47(12):941-3. PubMed ID: 19781253
[TBL] [Abstract][Full Text] [Related]
16. Hypertrophic scar fibroblasts have increased connective tissue growth factor expression after transforming growth factor-beta stimulation.
Colwell AS; Phan TT; Kong W; Longaker MT; Lorenz PH
Plast Reconstr Surg; 2005 Oct; 116(5):1387-90; discussion 1391-2. PubMed ID: 16217483
[TBL] [Abstract][Full Text] [Related]
17. [Mechanism of transcriptional regulation of Meox1 by transforming growth factor β (1) and its effect on cell migration of adult human dermal fibroblasts].
Wei ZY; Li HS; Zhou JY; Han C; Dong H; Wu YZ; He WF; Tian Y; Luo GX
Zhonghua Shao Shang Za Zhi; 2020 Mar; 36(3):224-233. PubMed ID: 32241049
[No Abstract] [Full Text] [Related]
18. Influence of Transforming Growth Factors beta 1 and beta 3 in the Scar Formation Process.
Lee JS; Cho HG; Lee JW; Oh EJ; Kim HM; Ko UH; Kang M; Shin JH; Chung HY
J Craniofac Surg; 2023 May; 34(3):904-909. PubMed ID: 36730874
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of DNA Methylation and Methyl-CpG-Binding Protein 2 Suppresses RPE Transdifferentiation: Relevance to Proliferative Vitreoretinopathy.
He S; Barron E; Ishikawa K; Nazari Khanamiri H; Spee C; Zhou P; Kase S; Wang Z; Dustin LD; Hinton DR
Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5579-89. PubMed ID: 26305530
[TBL] [Abstract][Full Text] [Related]
20. [Effect of the methylation enzyme inhibitors of 5-aza-2-deoxycytidine on the TGF-beta/smad signal transduction pathway in human keloid fibroblasts].
Zou QP; Yang E; Zhang HS
Zhonghua Zheng Xing Wai Ke Za Zhi; 2013 Jul; 29(4):285-9. PubMed ID: 24228511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
